How DMSA-IONPs Combat Breast Cancer Cell Migration

A recent study highlights the potential of nanotechnology in oncology. Specifically, researchers investigated how dimercaptosuccinic acid (DMSA)-coated iron oxide nanoparticles (IONPs) affect breast cancer cell migration. Metastatic cells often undergo metabolic changes that make them sensitive to redox shifts. Therefore, targeted pro-oxidant therapies represent a promising strategy for modern cancer treatment.

Impact on Breast Cancer Cell Migration

The research demonstrates that DMSA-IONPs effectively trigger reactive oxygen species (ROS) production via the Fenton Reaction. This oxidative burst leads to actin carbonylation within the cancer cells. Consequently, these changes drive significant cytoskeletal rearrangements. The cells experience a reduction in area and a decrease in the number of invadosomes. Notably, these structural changes directly impair breast cancer cell migration and invasion capabilities.

Disrupting Paracrine Cell Communication

Beyond structural impacts, the nanoparticles influence how tumor cells interact with their environment. They accumulate in endo-lysosomal compartments, which alters unconventional protein secretion pathways (UCPS). This process stimulates the release of multivesicular bodies while simultaneously blocking lysosomal and autophagosomal release. Such modifications shift the paracrine signals sent to endothelial cells. Ultimately, this disruption inhibits endothelial cell chemotaxis, which is vital for metastasis.

In conclusion, DMSA-IONPs offer a dual-action mechanism. They directly halt tumor cell movement and indirectly starve the tumor by interfering with its communication network. Furthermore, these findings suggest that nanoparticle-based therapies could become a cornerstone in managing metastatic breast cancer.

Frequently Asked Questions

How do DMSA-IONPs disrupt breast cancer cell migration?

DMSA-IONPs induce oxidative stress, which leads to the carbonylation of actin. This process alters the cell's cytoskeleton, reducing its ability to move and invade surrounding tissues.

What role does the Fenton Reaction play in this therapy?

The Fenton Reaction occurs when iron oxide nanoparticles interact with intracellular hydrogen peroxide. This reaction generates highly reactive hydroxyl radicals, increasing oxidative stress to levels that damage cancer cell structures.

How does this treatment affect the tumor microenvironment?

The nanoparticles modify protein secretion pathways in tumor cells. This change disrupts the paracrine communication between tumor and endothelial cells, further slowing the process of metastasis.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Daviu N et al. Oxidative stress induced by DMSA-IONPs impairs breast cancer cell migration and paracrine cell communication. J Nanobiotechnology. 2026 Apr 09. doi: 10.1186/s12951-026-04412-3. PMID: 41957669.

Portilla Y et al. DMSA-coated IONPs trigger oxidative stress, mitochondrial metabolic reprograming and changes in mitochondrial disposition, hindering cell cycle progression of cancer cells. Biomaterials. 2024 Jan;304:122409. doi: 10.1016/j.biomaterials.2023.122409.

Malik S et al. Targeting Oxidative Stress Biomarkers in Breast Cancer Development and the Potential Protective Effect of Phytochemicals. MDPI. 2025 May 23. doi: 10.3390/molecules30102456.